FDA Brief

Warning letters Drugs

FDA warning letter to

Plasticos Las Palmas, S.A. de C.V

High riskIssued Mar 1, 2021Posted Mar 9, 2021Center for Drug Evaluation and Research | CDER

FDA found Plasticos Las Palmas hand sanitizer labeled 70% ethanol contained mostly methanol and was refused at U.S. border.

What happened

FDA tested a batch of MEDICALLY MINDED Hand Sanitizer Gel that was declared to be manufactured at Plasticos Las Palmas and was detained at the U.S. border. The label said 70% ethanol, but FDA found on average 0.84% ethanol and 54% methanol. FDA also cited the product as an unapproved new drug and as misbranded.

What FDA found

  1. The hand sanitizer's labeled active ingredient, ethanol, was replaced in whole or in part with methanol, a dangerous chemical.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The methanol substitution showed that quality assurance at the facility was not working under CGMP requirements.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer was an unapproved new drug sold without an FDA-approved application.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  4. The label said the product contained 70% ethanol and did not disclose methanol, making the labeling false or misleading.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  5. The label did not list methanol as an ingredient.

    FD&C Act section 502(e)(1)(A), 21 U.S.C. 352(e)(1)(A)
  6. The product was dangerous to health when used according to its hand sanitizer labeling.

    FD&C Act section 502(j), 21 U.S.C. 352(j)

What FDA wants

FDA asks the firm to respond in writing within 15 working days with an investigation into the methanol substitution, raw material and supplier lists, shipment and batch reconciliation, and batch records, and to address the violations and prevent recurrence.

Who should pay attention

  • brands and distributors selling hand sanitizer made by contract manufacturers
  • U.S. importers and retailers sourcing Mexican hand sanitizer
  • companies relying on supplier certificates for ethanol ingredients

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk